deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02220621

Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion

A Prospective, Multi-center, Randomized, Controlled Clinical Study on Self-crosslinked Sodium Hyaluronate Gel for Prevention of Intrauterine Adhesion

Sponsor: Xiaozheng Shu

Updated 4 times since 2017 Last updated: Aug 18, 2014 Started: Oct 31, 2011 Primary completion: Apr 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Intrauterine Adhesion and is currently completed. Xiaozheng Shu leads this study, which shows 4 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 20 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2017 — Jan 2021 [monthly]

    Completed NA

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Xiaozheng Shu
Data source: BioRegen Biomedical (CHangzhou) Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .